エピソード

  • B+L Receives Approval in Europe for LuxLife IOL

    B+L Receives Approval in Europe for LuxLife IOL
    2025/05/14
    Bausch + Lomb receives CE Mark for a new full range of vision IOL; Aldeyra plans to once again resubmit a new drug application to the FDA for dry eye drug candidate reproxalap; and Topcon makes several deals to advance its AI and digital health solutions Learn more about your ad choices. Visit megaphone.fm/adchoices
    続きを読む 一部表示
    6 分
  • Ophthalmic Leaders Launch SightLine Meeting

    Ophthalmic Leaders Launch SightLine Meeting
    2025/05/07
    Commercial stakeholders discuss the challenges and opportunities in ophthalmology in this special edition of Eyewire News: The Podcast. Learn more about your ad choices. Visit megaphone.fm/adchoices
    続きを読む 一部表示
    10 分
  • Breaking News from the ASCRS Meeting in Los Angeles

    Breaking News from the ASCRS Meeting in Los Angeles
    2025/04/30
    EyewireTV reports on new products and breaking news live from the American Society of Cataract and Refractive Surgery (ASCRS) meeting in Los Angeles. Learn more about your ad choices. Visit megaphone.fm/adchoices
    続きを読む 一部表示
    14 分
  • FDA Issues CRL to Regeneron for Eylea HD Extended Dosing

    FDA Issues CRL to Regeneron for Eylea HD Extended Dosing
    2025/04/23
    The FDA responds to Regeneron’s request to extend dosing intervals for Eylea HD; Regeneron applies for a new indication for Eylea HD; and several recent executive appointments are announced in the ophthalmology industry. Learn more about your ad choices. Visit megaphone.fm/adchoices
    続きを読む 一部表示
    5 分
  • Orasis Launches Presbyopia Eye Drop Qlosi

    Orasis Launches Presbyopia Eye Drop Qlosi
    2025/04/16
    A presbyopia drop is officially launched in the US; Nordic Pharma receives European approval for its novel dry eye therapy; and Tenpoint submits an NDA for a presbyopia eye drop candidate. Learn more about your ad choices. Visit megaphone.fm/adchoices
    続きを読む 一部表示
    10 分
  • Utilizing AI to Provide DR Screening to Underserved Communities

    Utilizing AI to Provide DR Screening to Underserved Communities
    2025/04/09
    EyewireTV speaks with the leaders of Digital Diagnostics and AEYE Health about their diabetic screening technology, racial and socioeconomic disparities in eye care, and their mission to improve health equity by expanding their technology into underserved populations. Learn more about your ad choices. Visit megaphone.fm/adchoices
    続きを読む 一部表示
    18 分
  • Alcon Launches PanOptix Pro in US

    Alcon Launches PanOptix Pro in US
    2025/04/02
    Alcon introduces its next-generation trifocal IOL; Alcon announces a deal to advance its clinical-stage allogeneic cell therapy; and Bausch + Lomb announces a voluntary recall of IOLs on its enVista platform. Learn more about your ad choices. Visit megaphone.fm/adchoices
    続きを読む 一部表示
    7 分
  • Alcon Announces Plans to Acquire Lensar

    Alcon Announces Plans to Acquire Lensar
    2025/03/26
    Alcon makes a major acquisition to bolster its cataract surgery portfolio; Opthea releases phase results for its combination wet AMD candidate; and Bausch + Lomb announces results from a phase 4 extension study of dry eye disease drug Miebo. Learn more about your ad choices. Visit megaphone.fm/adchoices
    続きを読む 一部表示
    5 分